Early and late outcomes of a series of 255 patients with Crohn's disease who underwent resection: 10 years of experience at a single referral center.


Journal

Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 19 04 2022
accepted: 17 06 2022
pubmed: 17 7 2022
medline: 21 9 2022
entrez: 16 7 2022
Statut: ppublish

Résumé

Patients with Crohn's disease experience an increased risk of postoperative complications and disease recurrence. The aim of this study was to investigate the role of the risk factors in determining these outcomes and whether preoperative removal of some of these risk factors would optimize the results. We conducted a retrospective study analyzing a consecutive series of 255 patients who underwent surgical resection for Crohn's disease between 2010 and 2020. We considered short- and long-term endpoints, such as postoperative complications categorized according to the Clavien-Dindo classification and the appearance of surgical and endoscopic postoperative recurrence. Univariable and multivariable analyses showed that multiple and extensive localizations increased the incidence of postoperative complications (OR = 2.19; 95% CI 1.05-4.5; p = 0.035 and OR = 1.015; 95% CI 1.003-1.028; p = 0.017 for each cm of resected segment, respectively). Regarding theoretically modifiable factors, preoperative hypoalbuminemia (for each g/L reduction) increased the risk of complications with an OR = 1.1; 95% CI 1.02-1.12; p = 0.003. Preoperative steroid therapy exerted a similar effect, with an OR = 2.6; 95% CI 1.1-5.9; p = 0.018. Modifying these last two risk factors by improving the nutritional status or discontinuing steroid therapy significantly reduced complications.Microscopic positivity of the resection margins was a risk factor for surgical recurrence (OR = 8.7; 95% CI 1.9-40; p = 0.05). Based on the results of the present study, surgeons must examine modifiable risk factors, and careful preoperative tailored management may reduce postoperative complications and disease recurrence.

Identifiants

pubmed: 35841530
doi: 10.1007/s13304-022-01322-5
pii: 10.1007/s13304-022-01322-5
pmc: PMC9481492
doi:

Substances chimiques

Steroids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1657-1664

Informations de copyright

© 2022. The Author(s).

Références

Br J Surg. 2017 Nov;104(12):1713-1722
pubmed: 28745410
Gastroenterology. 2011 May;140(6):1785-94
pubmed: 21530745
JPEN J Parenter Enteral Nutr. 2019 Feb;43(2):181-193
pubmed: 30288759
Clin Nutr. 2017 Apr;36(2):321-347
pubmed: 28131521
Colorectal Dis. 2017 Sep 15;:
pubmed: 28913968
World J Surg. 2010 Jul;34(7):1615-26
pubmed: 20195604
Best Pract Res Clin Gastroenterol. 2003 Feb;17(1):63-73
pubmed: 12617883
Ann Surg. 1996 Oct;224(4):563-71; discussion 571-3
pubmed: 8857860
Am J Gastroenterol. 2008 Sep;103(9):2373-81
pubmed: 18616660
J Crohns Colitis. 2019 Dec 10;13(12):1583
pubmed: 31076765
J Crohns Colitis. 2019 Oct 28;13(11):1433-1438
pubmed: 31253985
Inflamm Bowel Dis. 2012 Dec;18(12):2404-13
pubmed: 22467533
Inflamm Bowel Dis. 2019 Jan 10;25(2):261-269
pubmed: 30052982

Auteurs

Franco Sacchetti (F)

Abdominal Surgery Unit, Fondazione Policlinico Universitario "A. Gemelli"-IRCCS, Largo Agostino Gemelli, 8, 00168, Rome, Italy.

Paola Caprino (P)

Abdominal Surgery Unit, Fondazione Policlinico Universitario "A. Gemelli"-IRCCS, Largo Agostino Gemelli, 8, 00168, Rome, Italy.

Angelo Eugenio Potenza (AE)

Abdominal Surgery Unit, Fondazione Policlinico Universitario "A. Gemelli"-IRCCS, Largo Agostino Gemelli, 8, 00168, Rome, Italy.

Dario Pastena (D)

Abdominal Surgery Unit, Fondazione Policlinico Universitario "A. Gemelli"-IRCCS, Largo Agostino Gemelli, 8, 00168, Rome, Italy.

Stefano Presacco (S)

Università Cattolica del Sacro Cuore di Roma, Rome, Italy.

Luigi Sofo (L)

Abdominal Surgery Unit, Fondazione Policlinico Universitario "A. Gemelli"-IRCCS, Largo Agostino Gemelli, 8, 00168, Rome, Italy. luigi.sofo@policlinicogemelli.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH